Cargando…
Targeting mitochondrial dysfunction with small molecules in intervertebral disc aging and degeneration
The prevalence of rheumatic and musculoskeletal diseases (RMDs) including osteoarthritis (OA) and low back pain (LBP) in aging societies present significant cost burdens to health and social care systems. Intervertebral disc (IVD) degeneration, which is characterized by disc dehydration, anatomical...
Autores principales: | Saberi, Morteza, Zhang, Xiaolei, Mobasheri, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110620/ https://www.ncbi.nlm.nih.gov/pubmed/33634362 http://dx.doi.org/10.1007/s11357-021-00341-1 |
Ejemplares similares
-
Mitochondrial Dysfunction in Oxidative Stress‐Mediated Intervertebral Disc Degeneration
por: Wang, Dian‐Kai, et al.
Publicado: (2022) -
Mitochondrial quality control in intervertebral disc degeneration
por: Song, Yu, et al.
Publicado: (2021) -
Degeneration of the intervertebral disc
por: Urban, Jill PG, et al.
Publicado: (2003) -
Small molecule natural compound agonist of SIRT3 as a therapeutic target for the treatment of intervertebral disc degeneration
por: Wang, Jianle, et al.
Publicado: (2018) -
Treatment of Intervertebral Disc Degeneration
por: Xin, Jingguo, et al.
Publicado: (2022)